Market Blog

Positive sentiments for Bluebird Bio and VMWare

BLUE – Bluebird Bio Inc is focused on developing and commercializing drugs based on gene therapy to treat patients with genetic diseases and cancer. BLUE – Bluebird Bio Inc Fundamentals Previously closed at 47.72 Day's high 51.46 Day's low 47.61 P/E ratio NA EPS -2.44   Analysts opinion Bluebird Bio announced that its ongoing phase 2 study evaluating the product candidate “Lenti-D” for the treatment of cerebral adrenoleukodystrophy (CALD) will
Market Blog

Bullish sentiments for Ardelyx, Inc and Target Corporation

ARDX– Ardelyx, Inc is a clinical stage bio-pharmaceutical company which develops therapeutic drugs for the treatment of Gastro-Intestinal and Cardio – Renal diseases. ARDX was given a “Buy”rating from Ladenburg Thalmann, and may be bullish today. ARDX – Ardelyx, Inc. Fundamentals Previously closed at 7.77 Day's high 8.02 Day's low 7.41 P/E ratio NA EPS -0.76   Analysts opinion Out of the 4 wall street analysts covering the stock, all